FDAnews Drug Daily Bulletin
Pharmaceuticals / Submissions and Approvals

FDA Clears Elite, SunGen’s Adderall Generic

Dec. 19, 2018

Elite Pharmaceuticals, in collaboration with SunGen Pharma, received the FDA’s approval for generic Adderall (amphetamine, dextroamphetamine).

The approval marks the first for the collaboration between Elite and SunGen Pharma, who will jointly own the product. Elite will manufacture and package the product.

The approval marks the fifth for Elite in 2018 with three ANDAs still pending.

View today's stories